Celgene has appointed Karen Browne as business unit director of haematology for its UK and Ireland business.
Over the past 15 years, Browne has held various sales, sales management and marketing positions in a number of companies, including Innovex UK and Nycomed UK.
She first joined Celgene in 2008 as a product manager in the UK and Ireland, and in this role she successfully built Celgene’s myelodysplastic syndrome (MDS) franchise.
She then relocated to Switzerland in March 2010, taking up the role of associate director of MDS and acute myeloid leukaemia (AML), and less than two years later was promoted to director with responsibility for overall MDS/AML marketing across Europe.
Samantha Pearce, general manager of Celgene UK and Ireland, said: “This new appointment will enable Karen to bring together her prior sales management and marketing experience to lead the unit.
“In her previous roles at Celgene, Karen has proven to be a passionate, committed and resourceful leader with the ability to inspire and motivate teams. The expertise Karen will bring from her European role will help us to improve the support we are able to provide people living with these rare diseases in the UK.”